Ambrx Biopharma Inc.
NYSE:AMAM
28 (USD) • At close March 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| -22.989 | -17.826 | -15.302 | -10.939 | -15.568 | -28.842 | -22.647 |
| Depreciation & Amortization
| 0.381 | 0.368 | 0.365 | 0.371 | 0.33 | 0.544 | 0.558 |
| Deferred Income Tax
| 0.526 | -0.028 | 0 | -0.22 | -0.233 | 0 | 0 |
| Stock Based Compensation
| 4.82 | 2.886 | 1.938 | 1.186 | 1.538 | 1.879 | 1.65 |
| Change In Working Capital
| -2.297 | 0.796 | -0.382 | -3.783 | -2.769 | 4.304 | -8.373 |
| Accounts Receivables
| -0.041 | -0.019 | 0.314 | 0.433 | 0.657 | 0.01 | -0.237 |
| Change In Inventory
| 0 | 0 | 0 | 2.521 | -4.976 | 0 | 0 |
| Change In Accounts Payables
| -0.734 | -0.732 | 3.886 | -5.193 | 2.503 | 1.781 | -0.92 |
| Other Working Capital
| -1.522 | 1.547 | -4.582 | -1.544 | -0.953 | 2.513 | -7.216 |
| Other Non Cash Items
| 0.682 | 0.654 | 0.414 | 0.682 | 0.925 | 7.584 | 3.148 |
| Operating Cash Flow
| -18.877 | -13.15 | -12.967 | -12.703 | -15.777 | -14.531 | -25.664 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -0.298 | -0.783 | 0 | -0.047 | -0.104 | -0.129 | -0.774 |
| Acquisitions Net
| 0 | 0 | 0 | -8.819 | -11.982 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | -40.645 | -9.421 | -12.13 | -63.301 | 0 |
| Sales Maturities Of Investments
| 6.462 | 9.964 | 70.199 | 27.206 | 11.982 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 8.819 | 11.982 | 0 | 0 |
| Investing Cash Flow
| 6.164 | 9.181 | 29.554 | 17.738 | -0.252 | -63.43 | -0.774 |
| Financing Activities: | |||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| -0.318 | 74.981 | 77.78 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 10.028 | 7.669 | -0.559 | 0.481 | 0.481 | -0.028 | -0.006 |
| Financing Cash Flow
| 9.71 | 82.65 | 77.221 | 0.481 | 0.481 | -0.028 | -0.006 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -3.003 | 78.681 | 93.808 | 4.529 | -14.561 | -77.989 | -26.444 |
| Cash At End Of Period
| 225.927 | 228.93 | 150.249 | 56.441 | 51.912 | 66.473 | 144.462 |